
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $51.1B | $43B | $39.3B | $39.9B | $40.2B | |
Revenue Growth (YoY) | 2.29% | -15.85% | -8.77% | 1.53% | 0.91% | |
Cost of Revenues | $35.1B | $27.8B | $25.4B | $26.6B | $26.8B | |
Gross Profit | $16B | $15.2B | $13.9B | $13.3B | $13.4B | |
Gross Profit Margin | 31.33% | 35.29% | 35.34% | 33.39% | 33.43% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $10.4B | $8.8B | $8.5B | $9.2B | $9B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $9.7B | $8.5B | $8.5B | $9.2B | $9B | |
Operating Income | $6.3B | $6.7B | $5.4B | $4.1B | $4.4B | |
Net Interest Expenses | $2.4B | $2.2B | $2B | $2.6B | $2.1B | |
EBT. Incl. Unusual Items | $5.1B | $4.8B | $13.6B | $1.8B | -$1.6B | |
Earnings of Discontinued Ops. | -- | $215.1M | -$257.4M | -$70.6M | -$23.6M | |
Income Tax Expense | $4.5B | $1.8B | $512.7M | $54.3M | $2.4B | |
Net Income to Company | $563.7M | $3B | $13.1B | $1.7B | -$4B | |
Minority Interest in Earnings | -$494.9M | -$623.2M | -$517.9M | -$396.2M | -$454.3M | |
Net Income to Common Excl Extra Items | $68.9M | $2.6B | $12.3B | $1.2B | -$4.5B | |
Basic EPS (Cont. Ops) | $0.02 | $0.90 | $4.46 | $0.46 | -$1.71 | |
Diluted EPS (Cont. Ops) | $0.02 | $0.89 | $4.44 | $0.46 | -$1.71 | |
Weighted Average Basic Share | $3B | $2.9B | $2.8B | $2.7B | $2.6B | |
Weighted Average Diluted Share | $3B | $2.9B | $2.8B | $2.7B | $2.6B | |
EBITDA | $24.5B | $19.6B | $26.9B | $16B | $12.5B | |
EBIT | $8.1B | $7.5B | $16.2B | $4.7B | $869.9M | |
Revenue (Reported) | $51.1B | $43B | $39.3B | $39.9B | $40.2B | |
Operating Income (Reported) | $6.3B | $6.7B | $5.4B | $4.1B | $4.4B | |
Operating Income (Adjusted) | $8.1B | $7.5B | $16.2B | $4.7B | $869.9M |
Period Ending | 2004-09-30 | 2005-09-30 | 2006-09-30 | 2007-09-30 | 2008-09-30 | |
---|---|---|---|---|---|---|
Revenue | $14.9B | $13B | $14.9B | $16.2B | $18.9B | |
Revenue Growth (YoY) | 60.54% | -12.79% | 14.79% | 8.3% | 16.57% | |
Cost of Revenues | $9.3B | $7.5B | -- | -- | -- | |
Gross Profit | $5.6B | $5.5B | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.4B | $2.3B | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $1.4B | $1.7B | -- | -- | -- | |
Operating Income | $4.2B | $3.8B | -$7.3B | -$9.9B | -$7.9B | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $4B | $3.5B | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | $169.4M | -- | -- | -- | |
Income Tax Expense | $764.1M | $1.1B | -- | -- | -- | |
Net Income to Company | $6.6B | $5B | -$6.5B | $10.3B | $4.1B | |
Minority Interest in Earnings | -$61M | -$38.5M | -- | -- | -- | |
Net Income to Common Excl Extra Items | $3.2B | $2.5B | -$5.4B | $3.1B | $2B | |
Basic EPS (Cont. Ops) | $1.01 | $0.82 | -$1.88 | $1.09 | $0.70 | |
Diluted EPS (Cont. Ops) | $1.01 | $0.82 | -$1.88 | $1.08 | $0.70 | |
Weighted Average Basic Share | $3.2B | $3B | $2.9B | $2.9B | $2.9B | |
Weighted Average Diluted Share | $3.2B | $3B | $2.9B | $2.9B | $2.9B | |
EBITDA | $4.2B | $3.8B | -$19.1B | -$5.8B | -$10.2B | |
EBIT | $4.2B | $3.8B | -$19.1B | -$5.8B | -$10.2B | |
Revenue (Reported) | $14.9B | $13B | $14.9B | $16.2B | $18.9B | |
Operating Income (Reported) | $4.2B | $3.8B | -$7.3B | -$9.9B | -$7.9B | |
Operating Income (Adjusted) | $4.2B | $3.8B | -$19.1B | -$5.8B | -$10.2B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $52B | $42.8B | $38.9B | $39.9B | $40.3B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $35.7B | $27.7B | $25.1B | $26.6B | $26.8B | |
Gross Profit | $16.3B | $15.1B | $13.8B | $13.3B | $13.5B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $10.5B | $8.7B | $8.4B | $9.2B | $9B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $9.9B | $8.5B | $8.4B | $9.2B | $9B | |
Operating Income | $6.4B | $6.6B | $5.4B | $4.2B | $4.5B | |
Net Interest Expenses | $2.4B | $2.2B | $1.9B | $2.6B | $2.1B | |
EBT. Incl. Unusual Items | $5.2B | $4.7B | $13.9B | $1.8B | -$1.5B | |
Earnings of Discontinued Ops. | -- | -- | -- | -$71.2M | -$22.4M | |
Income Tax Expense | $4.6B | $1.8B | $496.1M | $56.2M | $2.4B | |
Net Income to Company | $529.7M | $3B | $13.4B | $1.7B | -$3.9B | |
Minority Interest in Earnings | -$503.8M | -$617.5M | -$516.7M | -$397M | -$452.6M | |
Net Income to Common Excl Extra Items | $25.9M | $2.6B | $12.7B | $1.2B | -$4.3B | |
Basic EPS (Cont. Ops) | $0.01 | $0.88 | $4.57 | $0.46 | -$1.66 | |
Diluted EPS (Cont. Ops) | $0.01 | $0.88 | $4.56 | $0.46 | -$1.66 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $24.9B | $19.5B | $27B | $16.1B | $12.6B | |
EBIT | $8.2B | $7.4B | $16.5B | $4.8B | $992.6M | |
Revenue (Reported) | $52B | $42.8B | $38.9B | $39.9B | $40.3B | |
Operating Income (Reported) | $6.4B | $6.6B | $5.4B | $4.2B | $4.5B | |
Operating Income (Adjusted) | $8.2B | $7.4B | $16.5B | $4.8B | $992.6M |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $6.8B | $8.4B | $12.8B | $4.9B | $9.8B | |
Short Term Investments | $7.1B | $8.1B | $7.7B | $4.7B | $6.9B | |
Accounts Receivable, Net | $4.8B | $4.6B | $11.7B | $3.5B | $4B | |
Inventory | $792.5M | $933.1M | $1B | $613.4M | $667.8M | |
Prepaid Expenses | $1.3B | $973.3M | -- | $647.9M | $764.1M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $33.1B | $30.8B | $33.4B | $42.7B | $31B | |
Property Plant And Equipment | $48.3B | $45.5B | $41.4B | $30.8B | $33.2B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $37.2B | $35.6B | $30.1B | $26.9B | $22.2B | |
Other Intangibles | $25.6B | $23.8B | $21.4B | $15B | $14B | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $181.8B | $171.9B | $169.6B | $155.9B | $139.1B | |
Accounts Payable | $7.9B | $8.2B | $19.9B | $6.1B | $6.7B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $3.7B | $3B | -- | $2.4B | $2.5B | |
Other Current Liabilities | -- | -- | $68.7M | $51.8M | $58.4M | |
Total Current Liabilities | $33.7B | $37.6B | $35.5B | $31.6B | $24.6B | |
Long-Term Debt | $57.9B | $53.9B | -- | $45.2B | $40.7B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $114B | $108.2B | $99.3B | $90B | $80.7B | |
Common Stock | $5.6B | $5.4B | $5.2B | $5.2B | $4.7B | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $65.4B | $61.1B | $69.1B | $64.8B | $57.1B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $2.4B | $2.6B | $1.2B | $1.1B | $1.3B | |
Total Equity | $67.8B | $63.7B | $70.3B | $65.9B | $58.4B | |
Total Liabilities and Equity | $181.8B | $171.9B | $169.6B | $155.9B | $139.1B | |
Cash and Short Terms | $13.9B | $16.4B | $20.4B | $9.6B | $16.8B | |
Total Debt | $63B | $64.2B | $72.4B | $51.1B | $45.8B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $6.8B | $8.4B | $12.8B | $4.9B | $9.8B | |
Short Term Investments | $7.1B | $8.1B | $7.7B | $4.7B | $6.9B | |
Accounts Receivable, Net | $4.8B | $4.6B | $11.7B | $3.5B | $4B | |
Inventory | $792.5M | $933.1M | $1B | $613.4M | $667.8M | |
Prepaid Expenses | $1.3B | $973.3M | -- | $647.9M | $764.1M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $33.1B | $30.8B | $33.4B | $42.7B | $31B | |
Property Plant And Equipment | $48.3B | $45.5B | $41.4B | $30.8B | $33.2B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $37.2B | $35.6B | $30.1B | $26.9B | $22.2B | |
Other Intangibles | $25.6B | $23.8B | $21.4B | $15B | $14B | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $181.8B | $171.9B | $169.6B | $155.9B | $139.1B | |
Accounts Payable | $7.9B | $8.2B | $19.9B | $6.1B | $6.7B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $3.7B | $3B | -- | $2.4B | $2.5B | |
Other Current Liabilities | -- | -- | $68.7M | $51.8M | $58.4M | |
Total Current Liabilities | $33.7B | $37.6B | $35.5B | $31.6B | $24.6B | |
Long-Term Debt | $57.9B | $53.9B | -- | $45.2B | $40.7B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $114B | $108.2B | $99.3B | $90B | $80.7B | |
Common Stock | $5.6B | $5.4B | $5.2B | $5.2B | $4.7B | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $2.4B | $2.6B | $1.2B | $1.1B | $1.3B | |
Total Equity | $67.8B | $63.7B | $70.3B | $65.9B | $58.4B | |
Total Liabilities and Equity | $181.8B | $171.9B | $169.6B | $155.9B | $139.1B | |
Cash and Short Terms | $13.9B | $16.4B | $20.4B | $9.6B | $16.8B | |
Total Debt | $63B | $64.2B | $72.4B | $51.1B | $45.8B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $563.7M | $3B | $13.1B | $1.7B | -$4B | |
Depreciation & Amoritzation | $16.5B | $12.1B | $10.7B | $11.3B | $11.6B | |
Stock-Based Compensation | $170.4M | $191.8M | $60.4M | $106.4M | $73M | |
Change in Accounts Receivable | $679.3M | -$731.3M | -$506.4M | -$648M | -$831.2M | |
Change in Inventories | -$79.4M | -$198.8M | -$175.1M | $192.1M | $143.9M | |
Cash From Operations | $20.1B | $21B | $18.8B | $18B | $16.5B | |
Capital Expenditures | $10.1B | $8B | $8.1B | $7.4B | $7.2B | |
Cash Acquisitions | $499.6M | $1.2M | $7.2B | $388.6M | $14.9B | |
Cash From Investing | -$10.8B | -$8B | -$394.9M | -$6.6B | $5.1B | |
Dividends Paid (Ex Special Dividend) | -$2.8B | -$2.9B | -$2.6B | -$2.6B | -$1.9B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $5.1B | $3B | $4.2B | $1.7B | $5B | |
Long-Term Debt Repaid | -$14.3B | -$8.1B | -$10.9B | -$9.7B | -$13.9B | |
Repurchase of Common Stock | -$72.4M | -$2.4B | -$1.9B | -- | -$2B | |
Other Financing Activities | $583.6M | -$1.7B | -$3.8B | -$2B | -$501.5M | |
Cash From Financing | -$17.7B | -$11.3B | -$14B | -$17.2B | -$16.4B | |
Beginning Cash (CF) | $15.5B | $6.7B | $7.7B | $12.6B | $6.6B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$8.5B | $1.8B | $4.4B | -$5.9B | $5.2B | |
Ending Cash (CF) | $6.8B | $8.6B | $12.1B | $6.6B | $11.7B | |
Levered Free Cash Flow | $10B | $13B | $10.7B | $10.5B | $9.3B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $529.7M | $3B | $13.4B | $1.7B | -$3.9B | |
Depreciation & Amoritzation | $16.7B | $12.1B | $10.6B | $11.3B | $11.6B | |
Stock-Based Compensation | $172.9M | $190.7M | $59.2M | $106.6M | $74.8M | |
Change in Accounts Receivable | $701.9M | -$777.2M | -$429.9M | -$651.4M | -$878.9M | |
Change in Inventories | -$80.8M | -$194.2M | -$168.8M | $192.1M | $135.9M | |
Cash From Operations | $20.5B | $20.7B | $19B | $18B | $16.4B | |
Capital Expenditures | $10.3B | $8B | $8B | $7.5B | $7.2B | |
Cash Acquisitions | $499.4M | -$1.6M | $7.4B | $389.8M | $15B | |
Cash From Investing | -$11B | -$7.9B | -$134.5M | -$6.7B | $5.1B | |
Dividends Paid (Ex Special Dividend) | -$2.9B | -$2.8B | -$2.6B | -$2.6B | -$1.9B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $5.2B | $3B | $4.4B | $1.7B | $5.1B | |
Long-Term Debt Repaid | -$14.6B | -$8B | -$10.9B | -$9.8B | -$14B | |
Repurchase of Common Stock | -$74.7M | -$2.4B | -$1.9B | -- | -$2B | |
Other Financing Activities | $583.3M | -$1.7B | -$3.9B | -$2B | -$506.6M | |
Cash From Financing | -$18.1B | -$11.1B | -$14.2B | -$17.2B | -$16.4B | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$8.4B | $1.8B | $4.3B | -$6.1B | $5.1B | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $10.3B | $12.6B | $11B | $10.5B | $9.2B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.